Article info

Download PDFPDF
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis
  1. Correspondence to Priv.-Doz. Dr Dirk Meyer-Olson, Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany; meyer.dirk{at}mh-hannover.de
View Full Text

Citation

Mederacke I, Witte T, Wedemeyer H, et al
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis

Publication history

  • Accepted November 1, 2010
  • First published December 3, 2010.
Online issue publication 
May 27, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.